BICO Group company MatTek Life Sciences just announced an exciting collaboration with Charles River Laboratories!
ICYMI: MatTek, in collaboration with Charles River Laboratories has been awarded a grant from the Foundation for Chemistry Research & Initiatives to advance non-animal research. The program will develop a new approach method (NAM) for inhalation toxicology. As leaders in the field of human tissue engineering, and the creators of EpiAirway, MatTek is uniquely qualified to lend its expertise to the project. “This partnership marks a pivotal moment where innovation and collaboration will lead us toward safer and more reliable outcomes for all," said MatTek CEO Alex Armento. Read more: https://bit.ly/3z8QLrK #betterscience #NAMs